Novel monoclonal antibody specific for t
✍
Terrance G. Johns; Elisabeth Stockert; Gerd Ritter; Achim A. Jungbluth; H-J. Su
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
French
⚖ 592 KB
## Abstract In some respects, the EGFR appears to be an attractive target for tumor‐targeted antibody therapy: it is overexpressed in many types of epithelial tumor and inhibition of signaling often induces an anti‐tumor effect. The use of EGFR specific antibodies, however, may be limited by uptake